AnalystsRobert DriscollRobert Driscoll's Stock Forecasts
AnalystsRobert Driscoll
Sectors:
Industries:
Analyst Ranking
Top 2%
#59 out of 4587 analysts
Average Return
+34.52%
Win Rate
50%61 out of 122
Risk vs Reward
Poor
Good
Robert Driscoll's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Elevation Oncology IncELEV | +627.82% | $0.50 | $3.61 | 2023-11-06 - 2024-05-17 | Buy |
Janux Therapeutics IncJANX | +611.48% | $6.62 | $47.10 | 2023-11-08 - 2024-05-17 | Buy |
Five Prime Therapeutics IncFPRX | +494.68% | $6.39 | $38.00 | 2020-06-22 - 2021-04-15 | Buy |
Alpine Immune Sciences IncALPN | +414.33% | $12.63 | $64.96 | 2023-11-15 - 2024-05-16 | Buy |
Alpine Immune Sciences IncALPN | +403.57% | $12.90 | $64.96 | 2023-09-01 - 2024-05-16 | Buy |
Robert Driscoll Analyst Color
Get additional color on Robert Driscoll's coverage of popular stocks
Robert Driscoll's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | 7 | Hold | $65.00 | +0.05% | Reiterates | 4 days ago |
Cullinan Therapeutics IncCGEM | 2 | Buy | $36.00 | +55.37% | Reiterates | 4 days ago |
Tyra Biosciences IncTYRA | 5 | Buy | $28.00 | +53.34% | Reiterates | 10 days ago |
Cytomx Therapeutics IncCTMX | 7 | Buy | $8.00 | +323.28% | Upgrades | 11 days ago |
Arcus Biosciences IncRCUS | 5 | Buy | $30.00 | +77.51% | Reiterates | 11 days ago |
Igm Biosciences IncIGMS | 7 | Buy | $20.00 | +116.92% | Reiterates | 11 days ago |
Revolution Medicines IncRVMD | 1 | Buy | $46.00 | +16.72% | Maintains | 11 days ago |
Janux Therapeutics IncJANX | 6 | Buy | $74.00 | +57.11% | Maintains | 12 days ago |
Arvinas IncARVN | 5 | Buy | $52.00 | +59.12% | Reiterates | 12 days ago |
Ideaya Biosciences IncIDYA | 6 | Buy | $52.00 | +28.40% | Reiterates | 12 days ago |
Kura Oncology IncKURA | 5 | Buy | $37.00 | +66.89% | Reiterates | 17 days ago |
Elevation Oncology IncELEV | 7 | Buy | $8.00 | +121.61% | Reiterates | 17 days ago |
Adicet Bio IncACET | 7 | Buy | $5.00 | +212.50% | Reiterates | a month ago |
Geron CorpGERN | 7 | Buy | $6.00 | +57.48% | Reiterates | a month ago |
Foghorn Therapeutics IncFHTX | 5 | Buy | $13.00 | +135.93% | Reiterates | a month ago |
Black Diamond Therapeutics IncBDTX | 6 | Buy | $16.00 | +228.54% | Maintains | a month ago |
Aprea Therapeutics IncAPRE | 2 | Buy | $11.00 | +108.73% | Maintains | 2 months ago |
Compass Therapeutics IncCMPX | 2 | Buy | $8.00 | +400.00% | Reiterates | 2 months ago |
Zentalis Pharmaceuticals IncZNTL | 8 | Hold | $15.00 | +24.28% | Maintains | 3 months ago |
Monte Rosa Therapeutics IncGLUE | 1 | Buy | $11.00 | +111.54% | Initiates Coverage On | 3 months ago |
Omega Therapeutics IncOMGA | 3 | Buy | $12.00 | +397.93% | Reiterates | 4 months ago |
Replimune Group IncREPL | 4 | Buy | $52.00 | +707.45% | Reiterates | 6 months ago |
Day One Biopharmaceuticals IncDAWN | 5 | Buy | $35.00 | +116.45% | Maintains | 6 months ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $9.00 | +90.68% | Initiates Coverage On | 9 months ago |
Atreca IncBCEL | 4 | Hold | $1.00 | +566.67% | Downgrades | 9 months ago |
Cyteir Therapeutics IncCYTT | 3 | Buy | $3.00 | N/A | Reiterates | a year ago |
Tango Therapeutics IncTNGX | 2 | Buy | $18.00 | N/A | Reiterates | a year ago |
Surface Oncology IncSURF | 1 | Buy | $3.00 | N/A | Reiterates | a year ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | a year ago |
Harpoon Therapeutics IncHARP | 3 | Buy | $70.00 | N/A | Upgrades | 2 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Hold | $1.80 | N/A | Downgrades | 2 years ago |
Aceragen IncACGN | 2 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Five Prime Therapeutics IncFPRX | 4 | Buy | $9.00 | N/A | Upgrades | 4 years ago |
Arbutus Biopharma CorpABUS | 4 | Buy | $4.00 | N/A | Upgrades | 4 years ago |
Nabriva Therapeutics PLCNBRVF | 1 | Hold | $250.00 | N/A | Downgrades | 4 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Buy | $34.00 | N/A | Reiterates | 7 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $4.00 | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.